Pages that link to "Q26746220"
Jump to navigation
Jump to search
The following pages link to Advances in the treatment of type 2 diabetes: impact of dulaglutide (Q26746220):
Displaying 4 items.
- Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus (Q38778064) (← links)
- Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data. (Q55345557) (← links)
- Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial (Q88512145) (← links)
- Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1 (Q90703785) (← links)